Dr. Michael Tolwin, M.D

NPI: 1497797427
Total Payments
$16,771
2024 Payments
$1,589
Companies
22
Transactions
957
Medicare Patients
5,443
Medicare Billing
$1.4M

Payment Breakdown by Category

Food & Beverage$16,684 (99.5%)
Education$87.49 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $16,684 948 99.5%
Education $87.49 9 0.5%

Top Paying Companies

Company Total Records Latest Year
Sunovion Pharmaceuticals Inc. $2,328 106 $0 (2022)
Alkermes, Inc. $1,984 115 $0 (2024)
Janssen Pharmaceuticals, Inc $1,984 134 $0 (2024)
Lundbeck LLC $1,942 136 $0 (2024)
AbbVie Inc. $1,534 75 $0 (2023)
Vanda Pharmaceuticals Inc. $1,199 75 $0 (2024)
Otsuka America Pharmaceutical, Inc. $984.32 72 $0 (2024)
Allergan, Inc. $963.60 48 $0 (2020)
Neurocrine Biosciences, Inc. $935.64 46 $0 (2024)
ITI, Inc. $834.00 46 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,589 105 Janssen Pharmaceuticals, Inc ($473.45)
2023 $1,824 88 ITI, Inc. ($434.57)
2022 $1,003 46 ABBVIE INC. ($557.35)
2021 $1,462 73 AbbVie Inc. ($712.02)
2020 $2,014 104 Sunovion Pharmaceuticals Inc. ($675.69)
2019 $2,761 168 Lundbeck LLC ($659.50)
2018 $3,144 184 Sunovion Pharmaceuticals Inc. ($481.73)
2017 $2,974 189 Sunovion Pharmaceuticals Inc. ($482.47)

All Payment Transactions

957 individual payment records from CMS Open Payments — Page 1 of 39

Date Company Product Nature Form Amount Type
12/17/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $19.89 General
Category: SCHIZOPHRENIA
12/17/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $13.44 General
Category: SCHIZOPHRENIA
12/10/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $13.03 General
Category: CNS
12/10/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $12.14 General
Category: CNS
12/03/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $20.31 General
Category: CNS
12/03/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $5.40 General
Category: CNS
11/26/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $22.51 General
Category: Neuroscience
11/26/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $11.10 General
Category: Neuroscience
11/26/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $1.89 General
Category: Neuroscience
11/19/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $15.51 General
Category: CNS
11/19/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $11.93 General
Category: CNS
11/12/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $20.09 General
Category: CNS
11/12/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $5.40 General
Category: CNS
11/05/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $14.93 General
Category: Neuropsychiatry
11/05/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $14.08 General
Category: Neuropsychiatry
10/22/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $13.22 General
Category: Neuroscience
10/22/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $10.60 General
Category: Neuroscience
10/22/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $2.47 General
Category: Neuroscience
10/22/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $2.26 General
Category: Neuroscience
10/15/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $17.81 General
Category: Neuroscience
10/15/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $5.75 General
Category: Neuroscience
10/15/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $3.04 General
Category: Neuroscience
10/08/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $13.82 General
Category: CNS
10/08/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $13.82 General
Category: CNS
10/01/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $16.20 General
Category: CNS

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 1,566 5,084 $606,525 $350,132
2022 10 1,391 6,334 $724,625 $417,372
2021 10 1,289 4,935 $564,200 $344,675
2020 13 1,197 4,951 $527,675 $306,982
Total Patients
5,443
Total Services
21,304
Medicare Billing
$1.4M
Procedure Codes
53

All Medicare Procedures & Services

53 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90833 Psychotherapy with evaluation and management visit, 30 minutes Facility 2023 335 1,979 $197,900 $101,356 51.2%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 192 530 $68,650 $52,059 75.8%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 163 759 $75,975 $50,314 66.2%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 263 266 $66,875 $37,929 56.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 102 367 $45,775 $26,947 58.9%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2023 102 363 $36,300 $20,249 55.8%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 42 381 $38,100 $15,709 41.2%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 86 118 $20,925 $12,734 60.9%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 117 117 $20,475 $11,308 55.2%
90792 Psychiatric diagnostic evaluation with medical services Facility 2023 51 70 $17,500 $9,761 55.8%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 65 84 $8,400 $5,739 68.3%
90792 Psychiatric diagnostic evaluation with medical services Office 2023 23 23 $5,750 $3,557 61.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 12 13 $2,125 $1,436 67.6%
90836 Psychotherapy with evaluation and management visit, 45 minutes Office 2023 13 14 $1,775 $1,033 58.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 186 1,346 $168,225 $101,474 60.3%
90833 Psychotherapy with evaluation and management visit, 30 minutes Facility 2022 240 1,650 $165,000 $87,506 53.0%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2022 184 1,235 $123,500 $71,489 57.9%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 142 423 $52,950 $36,615 69.2%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 203 205 $51,250 $33,787 65.9%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 109 492 $49,200 $29,590 60.1%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 39 638 $52,150 $20,726 39.7%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 69 94 $16,625 $10,618 63.9%
90792 Psychiatric diagnostic evaluation with medical services Office 2022 67 68 $17,000 $9,356 55.0%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 66 67 $11,725 $6,018 51.3%
90792 Psychiatric diagnostic evaluation with medical services Facility 2022 26 36 $9,000 $5,283 58.7%

About Dr. Michael Tolwin, M.D

Dr. Michael Tolwin, M.D is a Psychiatry healthcare provider based in Culver City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497797427.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Tolwin, M.D has received a total of $16,771 in payments from pharmaceutical and medical device companies, with $1,589 received in 2024. These payments were reported across 957 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($16,684).

As a Medicare-enrolled provider, Tolwin has provided services to 5,443 Medicare beneficiaries, totaling 21,304 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Culver City, CA
  • Active Since 06/12/2006
  • Last Updated 07/12/2023
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1497797427

Products in Payments

  • VRAYLAR (Drug) $2,474
  • LATUDA (Drug) $2,328
  • INVEGA SUSTENNA (Drug) $1,377
  • REXULTI (Drug) $1,255
  • CAPLYTA (Drug) $1,177
  • ARISTADA (Drug) $1,031
  • INGREZZA (Drug) $935.64
  • Aristada 441 mg (Drug) $849.69
  • ABILIFY MAINTENA (Drug) $814.65
  • Fanapt (Drug) $742.10
  • AUSTEDO (Drug) $504.20
  • INVEGA TRINZA (Drug) $421.88
  • Trintellix (Drug) $419.16
  • HETLIOZ (Drug) $354.31
  • TRINTELLIX (Drug) $343.91
  • PERSERIS (Drug) $265.60
  • BRINTELLIX (Drug) $199.98
  • Wakix (Drug) $192.86
  • ABILIFY MYCITE (Drug) $186.72
  • NUEDEXTA (Drug) $145.69

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Culver City